253 related articles for article (PubMed ID: 3514450)
1. Activation of the complement system by Cryptococcus neoformans leads to binding of iC3b to the yeast.
Kozel TR; Pfrommer GS
Infect Immun; 1986 Apr; 52(1):1-5. PubMed ID: 3514450
[TBL] [Abstract][Full Text] [Related]
2. Activation and binding of opsonic fragments of C3 on encapsulated Cryptococcus neoformans by using an alternative complement pathway reconstituted from six isolated proteins.
Kozel TR; Wilson MA; Pfrommer GS; Schlageter AM
Infect Immun; 1989 Jul; 57(7):1922-7. PubMed ID: 2525113
[TBL] [Abstract][Full Text] [Related]
3. Activation and binding of C3 by Candida albicans.
Kozel TR; Brown RR; Pfrommer GS
Infect Immun; 1987 Aug; 55(8):1890-4. PubMed ID: 3301679
[TBL] [Abstract][Full Text] [Related]
4. Strain variation in phagocytosis of Cryptococcus neoformans: dissociation of susceptibility to phagocytosis from activation and binding of opsonic fragments of C3.
Kozel TR; Pfrommer GS; Guerlain AS; Highison BA; Highison GJ
Infect Immun; 1988 Nov; 56(11):2794-800. PubMed ID: 3049374
[TBL] [Abstract][Full Text] [Related]
5. Accelerated decay of C3b to iC3b when C3b is bound to the Cryptococcus neoformans capsule.
Pfrommer GS; Dickens SM; Wilson MA; Young BJ; Kozel TR
Infect Immun; 1993 Oct; 61(10):4360-6. PubMed ID: 8406826
[TBL] [Abstract][Full Text] [Related]
6. Deposition of C3b and iC3b onto particulate activators of the human complement system. Quantitation with monoclonal antibodies to human C3.
Newman SL; Mikus LK
J Exp Med; 1985 Jun; 161(6):1414-31. PubMed ID: 2409200
[TBL] [Abstract][Full Text] [Related]
7. Activation of C3 and binding to Aspergillus fumigatus conidia and hyphae.
Kozel TR; Wilson MA; Farrell TP; Levitz SM
Infect Immun; 1989 Nov; 57(11):3412-7. PubMed ID: 2680973
[TBL] [Abstract][Full Text] [Related]
8. Activation, binding, and processing of complement component 3 (C3) by Blastomyces dermatitidis.
Zhang MX; Klein B
Infect Immun; 1997 May; 65(5):1849-55. PubMed ID: 9125571
[TBL] [Abstract][Full Text] [Related]
9. Contribution of antibody in normal human serum to early deposition of C3 onto encapsulated and nonencapsulated Cryptococcus neoformans.
Wilson MA; Kozel TR
Infect Immun; 1992 Mar; 60(3):754-61. PubMed ID: 1541548
[TBL] [Abstract][Full Text] [Related]
10. Activation of the complement system by the capsule of Cryptococcus neoformans.
Kozel TR
Curr Top Med Mycol; 1993; 5():1-26. PubMed ID: 8242797
[TBL] [Abstract][Full Text] [Related]
11. Kinetic analysis of the amplification phase for activation and binding of C3 to encapsulated and nonencapsulated Cryptococcus neoformans.
Kozel TR; Wilson MA; Welch WH
Infect Immun; 1992 Aug; 60(8):3122-7. PubMed ID: 1639481
[TBL] [Abstract][Full Text] [Related]
12. Analysis of C3 deposition and degradation on bacterial surfaces after opsonization.
Gordon DL; Rice J; Finlay-Jones JJ; McDonald PJ; Hostetter MK
J Infect Dis; 1988 Apr; 157(4):697-704. PubMed ID: 3279137
[TBL] [Abstract][Full Text] [Related]
13. Distinct characteristics of initiation of the classical and alternative complement pathways by Candida albicans.
Kozel TR; Weinhold LC; Lupan DM
Infect Immun; 1996 Aug; 64(8):3360-8. PubMed ID: 8757876
[TBL] [Abstract][Full Text] [Related]
14. Role of the capsule in phagocytosis of Cryptococcus neoformans.
Kozel TR; Pfrommer GS; Guerlain AS; Highison BA; Highison GJ
Rev Infect Dis; 1988; 10 Suppl 2():S436-9. PubMed ID: 3055212
[TBL] [Abstract][Full Text] [Related]
15. Generation of three different fragments of bound C3 with purified factor I or serum. II. Location of binding sites in the C3 fragments for factors B and H, complement receptors, and bovine conglutinin.
Ross GD; Newman SL; Lambris JD; Devery-Pocius JE; Cain JA; Lachmann PJ
J Exp Med; 1983 Aug; 158(2):334-52. PubMed ID: 6224880
[TBL] [Abstract][Full Text] [Related]
16. Effects of strain variation, serotype, and structural modification on kinetics for activation and binding of C3 to Cryptococcus neoformans.
Young BJ; Kozel TR
Infect Immun; 1993 Jul; 61(7):2966-72. PubMed ID: 8514401
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylation of C3 by a casein kinase released from activated human platelets increases opsonization of immune complexes and binding to complement receptor type 1.
Nilsson-Ekdahl K; Nilsson B
Eur J Immunol; 2001 Apr; 31(4):1047-54. PubMed ID: 11298329
[TBL] [Abstract][Full Text] [Related]
18. In vivo complement activation and binding of C3 to encapsulated Cryptococcus neoformans.
Truelsen K; Young T; Kozel TR
Infect Immun; 1992 Sep; 60(9):3937-9. PubMed ID: 1500204
[TBL] [Abstract][Full Text] [Related]
19. Bovine conglutinin binds to an oligosaccharide determinant presented by iC3b, but not by C3, C3b or C3c.
Laursen SB; Thiel S; Teisner B; Holmskov U; Wang Y; Sim RB; Jensenius JC
Immunology; 1994 Apr; 81(4):648-54. PubMed ID: 7518801
[TBL] [Abstract][Full Text] [Related]
20. Role of serum factors in the phagocytosis of weakly or heavily encapsulated Cryptococcus neoformans strains by guinea pig peripheral blood leukocytes.
Ikeda R; Shinoda T; Kagaya K; Fukazawa Y
Microbiol Immunol; 1984; 28(1):51-61. PubMed ID: 6374392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
